Emotra has previously announced that new research results have indicated new application areas for Emotra’s method, EDOR. These areas open new possibilities for widening the method’s use in clinical practice. We can now reveal that the application in question concerns the fact that hyporeactive patients run a higher risk of depression relapse than normally reactive patients.

 

190509- Emotra – PM – EDOR identifies patients with a higher risk of depression relapse